MYLOTARG – Gemtuzumabozogamicin uses, dose and side effects
MYLOTARG contains the active substance gemtuzumabozogamicin, an anticancer medicine, which consists of a monoclonal antibody bound to a substance which is intended to kill cancer cells. This substance is delivered to the cancer cells by the monoclonal antibody . A monoclonal antibody is a protein that recognizes certain cancer cells.
Read More